doc.aiis developing A.I. technologies to collect structured and real-world medical data to create engaging products, accelerate medical research and transform approaches to care. Their poly-omics data pipeline handles all forms of medical data to make it ready for analysis and model building. The company's primary consumer offering is a medical research companion app for personal-omics collection and digital health trials where participants can earn financial rewards. Additionally, they license A.I. modules and create products for a portfolio of clients, including payors, pharma, providers and patient organizations.
资金
员工
为你发现最好的职业机会和最好的公司文化。
将您的业务与您所在城市及其他地区数以千计的专业人士联系起来。